Quarterly report pursuant to Section 13 or 15(d)

Note 17 - Earnings Per Share - Summary of Antidilutive Securities (Details)

v3.22.2
Note 17 - Earnings Per Share - Summary of Antidilutive Securities (Details) - shares
3 Months Ended 6 Months Ended
May 31, 2022
May 31, 2021
May 31, 2022
May 31, 2021
Antidilutive Securities (in shares) 1,107,655 688,000 1,107,655 586,493
Share-Based Payment Arrangement, Option [Member]        
Antidilutive Securities (in shares) 320,533 638,000 320,533 518,000
Restricted Stock Units (RSUs) [Member]        
Antidilutive Securities (in shares) 787,122 50,000 787,122 68,493